ARCHIVES

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 30 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Nixon National Cancer Conference Kicks Off

December 8, 2021

In Brief: Columbia-Presbyterian Cancer center to Be Renamed After Donor Herbert Irving

December 6, 1996

In Brief: Simone Moves To huntsman Foundation, Golde Names MSK Physician-In-Chief

January 26, 1996

Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms

March 5, 1999

In Brief: McDonough Leaves Komen Foundation; Henderson To Head Salk Institute; Alabama Recruits Two

December 4, 1992

Bristol-Myers Survey Predicts Year 2000 Survival of 66%

April 3, 1987